Browse by popular tags
abvd act acute lymphoblastic leukaemia acute myelogenous leukemia (aml) acute myeloid leukaemia ade admire adoptive cellular therapy after 2 prior treatments alemtuzumab all allogeneic allogeneic stem cell transplant aml aml 17 angioimmunoblastic lymphoma antiviral therapy arctic autologous stem cell transplant autologous transplant azacitidine b-cell b-cell chronic lymphocytic leukaemia bexarotene blood cancers blood transfusions bone marrow bortezomib campath
NHS Logo
The Clinical research facility is part of the NIHR and is funded by the Department of Health
A phase I dose escalation study to establish the maximal tolerated dose of Campath in combination with CHOP and to assess the toxicity of the combination in the primary treatment of peripheral T cell lymphoma (PTCL).